解码败血症诱导的传播性血管内凝血:对现有和新兴疗法的全面审查
Ahsanullah Unar1, Lorenzo Bertolino1, Fabian Patauner1
1Department of Precision Medicine, University of Campania 'L. Vanvitelli', 80138 Naples, Italy.
Journal of clinical medicine
|October 14, 2023
概括
分布式血管内凝血 (DIC) 是一种严重的败血症并发症. 本综述分析了皮质类固醇和免疫调节疗法等治疗方法,强调需要随机试验来改善患者的治疗结果.
科学领域:
- 关键护理医学 关键护理医学
- 血液学 血液学 血液学
- 传染病 传染病 传染病
背景情况:
- 分布式血管内凝血 (DIC) 经常会复杂化败血症,导致器官功能障碍和预后不佳.
- 了解败血症引起的DIC机制对于早期诊断和有效管理至关重要.
- 目前的治疗策略面临着挑战,尽管正在进行研究.
研究的目的:
- 审查和分析目前和新兴的治疗策略,用于败血症诱导的DIC.
- 评估各种治疗方法的有效性和局限性.
- 在COVID-19的背景下探索DIC的潜在治疗方法.
主要方法:
- 关于败血症诱导的DIC治疗的综合文献综述.
- 对皮质类固醇,复合血栓模块素,维生素C和血小板输血的分析.
- 检查免疫调节疗法,包括G-CSF,GM-CSF,IFN-γ和MSC疗法.
主要成果:
- 讨论了各种治疗方法,包括皮质类固醇,rTM,维生素C和血小板输血.
- 免疫调节疗法 (IMT) 如G-CSF,GM-CSF,IFN-γ和MSC疗法正在探索中.
- 该审查考虑了这些疗法对COVID-19相关的DIC的影响.
结论:
- 有针对性的随机试验对于验证治疗疗效和发现败血症引起的DIC的新疗法至关重要.
- 更好地了解败血症引起的DIC病理生理学可以指导开发拯救生命的干预措施.
- 需要进一步的研究来优化治疗策略,提高患者的生存率.
相关概念视频
01:29Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
10
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
10
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
726
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
726
01:20Extrinsic and Intrinsic Pathways of Hemostasis
8.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.1K
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
13
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
13
01:24Disorders of Hemostasis
968
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
968